Secondary prevention of myocardial infarction--the present state of the ART.
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D012008:Recurrence; D013442:Sulfinpyrazone / Q000494:pharmacology / Q000627:therapeutic use*; D013927:Thrombosis / Q000150:complications / Q000517:prevention & control
D000925:Anticoagulants; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone